Integrated Research Group, Inc.

Riverside, California 92506

0 studies enrolling now · 14 studies all time

What they study most

Actinic Keratosis, Asthma, Atopic Dermatitis, Chronic Obstructive Pulmonary Disease (COPD), Chronic Sinusitis, Diabetes Mellitus, Type 2, Hypertension, Papulopustular Rosacea, Post Herpetic Neuralgia, Type 2 Diabetes, Urticaria

Studies at this site

• A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma — Completed
• Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis — Completed
• Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients — Completed
• Albuterol HFA MDI in Pediatric Participants With Asthma — Completed
• Phase 3 Papulopustular Rosacea Study — Completed
• Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia — Completed
• A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU). — Completed
• A Study to Evaluate the Long-term Safety and Efficacy of Fenebrutinib in Participants Previously Enrolled in a Fenebrutinib Chronic Spontaneous Urticaria (CSU) Study — Stopped early
• 24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension — Completed
• A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD — Completed
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker — Completed
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication — Completed
• A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp) — Completed
• Amphotericin B Suspension in Refractory Chronic Sinusitis — Completed